학술논문

Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
Document Type
Journal
Source
ANNALS OF NEUROLOGY; SEP 2023, 94 pS244-pS245, 2p. Supplement: 30
Subject
Language
English
ISSN
15318249